Facebook Comments
Related Articles
FDA -Recall of Some IV Chemo Drugs
Hospira Announces A Nationwide Recall of Certain Lots of Injectable Carboplatin, Cytarabine, Paclitaxel and Methotrexate Due to Glass Vial Defect FOR IMMEDIATE RELEASE -July 13, 2012 – Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, issued this press release today to further inform the general public about a previously […]